251 related articles for article (PubMed ID: 26108564)
21. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
[TBL] [Abstract][Full Text] [Related]
22. Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI.
Jones KM; Randtke EA; Yoshimaru ES; Howison CM; Chalasani P; Klein RR; Chambers SK; Kuo PH; Pagel MD
Mol Imaging Biol; 2017 Aug; 19(4):617-625. PubMed ID: 27896628
[TBL] [Abstract][Full Text] [Related]
23. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T.
Longo DL; Dastrù W; Digilio G; Keupp J; Langereis S; Lanzardo S; Prestigio S; Steinbach O; Terreno E; Uggeri F; Aime S
Magn Reson Med; 2011 Jan; 65(1):202-11. PubMed ID: 20949634
[TBL] [Abstract][Full Text] [Related]
24. Quantification of iopamidol multi-site chemical exchange properties for ratiometric chemical exchange saturation transfer (CEST) imaging of pH.
Sun PZ; Longo DL; Hu W; Xiao G; Wu R
Phys Med Biol; 2014 Aug; 59(16):4493-504. PubMed ID: 25054859
[TBL] [Abstract][Full Text] [Related]
25. Dual assessment of kidney perfusion and pH by exploiting a dynamic CEST-MRI approach in an acute kidney ischemia-reperfusion injury murine model.
Irrera P; Consolino L; Cutrin JC; Zöllner FG; Longo DL
NMR Biomed; 2020 Jun; 33(6):e4287. PubMed ID: 32153058
[TBL] [Abstract][Full Text] [Related]
26. MRI Appearance of Intracerebral Iodinated Contrast Agents: Is It Possible to Distinguish Extravasated Contrast Agent from Hemorrhage?
Nikoubashman O; Jablawi F; Dekeyzer S; Oros-Peusquens AM; Abbas Z; Lindemeyer J; Othman AE; Shah NJ; Wiesmann M
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1418-21. PubMed ID: 27032975
[TBL] [Abstract][Full Text] [Related]
27. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST-MRI tumor pH imaging.
Romdhane F; Villano D; Irrera P; Consolino L; Longo DL
Magn Reson Med; 2021 Jun; 85(6):3479-3496. PubMed ID: 33496986
[TBL] [Abstract][Full Text] [Related]
29. [Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
Grönewäller EF; Wahl HG; Kehlbach R; Rodemann HP; Claussen CD; Duda SH
Rofo; 1998 Nov; 169(5):537-41. PubMed ID: 9849607
[TBL] [Abstract][Full Text] [Related]
30. Measuring extracellular pH in a lung fibrosis model with acidoCEST MRI.
Jones KM; Randtke EA; Howison CM; Cárdenas-Rodríguez J; Sime PJ; Kottmann MR; Pagel MD
Mol Imaging Biol; 2015 Apr; 17(2):177-84. PubMed ID: 25187227
[TBL] [Abstract][Full Text] [Related]
31. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Druy EM; Bettmann MA; Jeans W
Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo porcine model to measure pH dependence of chemical exchange saturation transfer effect of glycosaminoglycan in the intervertebral disc.
Melkus G; Grabau M; Karampinos DC; Majumdar S
Magn Reson Med; 2014 May; 71(5):1743-9. PubMed ID: 23818244
[TBL] [Abstract][Full Text] [Related]
33. Measuring in vivo tumor pHe with CEST-FISP MRI.
Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
[TBL] [Abstract][Full Text] [Related]
34. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
[TBL] [Abstract][Full Text] [Related]
35. Monitor Tumor pHe and Response Longitudinally during Treatment Using CEST MRI-Detectable Alginate Microbeads.
Xiao P; Huang J; Han X; Cheu JWS; Liu Y; Law LH; Lai JHC; Li J; Park SW; Wong CCL; Lam RHW; Chan KWY
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54401-54410. PubMed ID: 36448714
[TBL] [Abstract][Full Text] [Related]
36. A generalized ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using iopamidol.
Wu Y; Zhou IY; Igarashi T; Longo DL; Aime S; Sun PZ
Magn Reson Med; 2018 Mar; 79(3):1553-1558. PubMed ID: 28686805
[TBL] [Abstract][Full Text] [Related]
37. Analysis Protocol for the Quantification of Renal pH Using Chemical Exchange Saturation Transfer (CEST) MRI.
Kim H; Wu Y; Villano D; Longo DL; McMahon MT; Sun PZ
Methods Mol Biol; 2021; 2216():667-688. PubMed ID: 33476030
[TBL] [Abstract][Full Text] [Related]
38. Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI.
Aime S; Calabi L; Biondi L; De Miranda M; Ghelli S; Paleari L; Rebaudengo C; Terreno E
Magn Reson Med; 2005 Apr; 53(4):830-4. PubMed ID: 15799043
[TBL] [Abstract][Full Text] [Related]
39. The impact of iodinated X-ray contrast agents on formation and toxicity of disinfection by-products in drinking water.
Jeong CH; Machek EJ; Shakeri M; Duirk SE; Ternes TA; Richardson SD; Wagner ED; Plewa MJ
J Environ Sci (China); 2017 Aug; 58():173-182. PubMed ID: 28774606
[TBL] [Abstract][Full Text] [Related]
40. Development of cationic peptide-based hydrogels loaded with iopamidol for CEST-MRI detection.
Di Gregorio E; Rosa E; Ferrauto G; Diaferia C; Gallo E; Accardo A; Terreno E
J Mater Chem B; 2023 Aug; 11(31):7435-7441. PubMed ID: 37435712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
